The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Across social media and encrypted messaging apps, a new frontier of weight loss is unfolding in real time, with people sourcing and injecting an experimental drug that regulators have not yet approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results